Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued to clients and investors on Thursday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Up 733.3 %

Shares of CALA stock opened at $0.01 on Thursday. Calithera Biosciences has a 1-year low of $0.00 and a 1-year high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.